NO841518L - Delbare tabletter med forsinket frigjoering av virkestoff, og fremgangsmaate for fremstilling derav - Google Patents

Delbare tabletter med forsinket frigjoering av virkestoff, og fremgangsmaate for fremstilling derav

Info

Publication number
NO841518L
NO841518L NO841518A NO841518A NO841518L NO 841518 L NO841518 L NO 841518L NO 841518 A NO841518 A NO 841518A NO 841518 A NO841518 A NO 841518A NO 841518 L NO841518 L NO 841518L
Authority
NO
Norway
Prior art keywords
procedure
producing
active substance
delayed delivery
dividable tablets
Prior art date
Application number
NO841518A
Other languages
English (en)
Other versions
NO164957B (no
NO164957C (no
Inventor
Bernd Zierenberg
Arun Rajaram Gupte
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6196696&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO841518(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of NO841518L publication Critical patent/NO841518L/no
Publication of NO164957B publication Critical patent/NO164957B/no
Publication of NO164957C publication Critical patent/NO164957C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Saccharide Compounds (AREA)
NO841518A 1983-04-18 1984-04-16 Fremgangsmaate for fremstilling av en delbar tablett paa polyakrylbasis, hvor bruddstykkene av den oppdelte tablett viser samme virkestofffrigjoeringskarakteristikk som den uoppdelte tablett. NO164957C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833314003 DE3314003A1 (de) 1983-04-18 1983-04-18 Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung

Publications (3)

Publication Number Publication Date
NO841518L true NO841518L (no) 1984-10-19
NO164957B NO164957B (no) 1990-08-27
NO164957C NO164957C (no) 1990-12-05

Family

ID=6196696

Family Applications (1)

Application Number Title Priority Date Filing Date
NO841518A NO164957C (no) 1983-04-18 1984-04-16 Fremgangsmaate for fremstilling av en delbar tablett paa polyakrylbasis, hvor bruddstykkene av den oppdelte tablett viser samme virkestofffrigjoeringskarakteristikk som den uoppdelte tablett.

Country Status (27)

Country Link
US (3) US4547359A (no)
EP (1) EP0122574B2 (no)
JP (1) JPH0623096B2 (no)
KR (1) KR910001924B1 (no)
AT (1) ATE23110T1 (no)
AU (1) AU575045B2 (no)
CA (1) CA1232202A (no)
CS (1) CS247079B2 (no)
DD (1) DD223063A5 (no)
DE (2) DE3314003A1 (no)
DK (1) DK161183C (no)
ES (1) ES8504453A1 (no)
FI (1) FI80590C (no)
GB (1) GB2138290B (no)
GR (1) GR79858B (no)
HK (1) HK1690A (no)
HU (1) HU191558B (no)
IE (1) IE57141B1 (no)
IL (1) IL71558A (no)
NO (1) NO164957C (no)
NZ (1) NZ207876A (no)
PH (1) PH19612A (no)
PL (1) PL144291B1 (no)
PT (1) PT78434B (no)
SG (1) SG68889G (no)
SU (1) SU1356951A3 (no)
ZA (1) ZA842815B (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3314003A1 (de) * 1983-04-18 1984-10-18 Boehringer Ingelheim KG, 6507 Ingelheim Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
DE3525767A1 (de) * 1985-07-19 1987-01-22 Boehringer Ingelheim Kg Pharmazeutische zubereitung mit kontrollierter und verzoegerter wirkstofffreigabe und verfahren zu deren herstellung
US4970075A (en) * 1986-07-18 1990-11-13 Euroceltique, S.A. Controlled release bases for pharmaceuticals
EP0359746B1 (en) * 1987-03-25 1992-06-03 E.I. Du Pont De Nemours And Company Use of vinyl alcohol homopolymers and copolymers for tableting active materials
GB8707416D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
US5051261A (en) * 1987-11-24 1991-09-24 Fmc Corporation Method for preparing a solid sustained release form of a functionally active composition
US5445830A (en) * 1989-07-25 1995-08-29 Otsuka Pharmaceutical Co., Ltd. Highly absorbable pharmaceutical composition
DE4029591C2 (de) * 1990-09-19 1995-01-26 Stockhausen Chem Fab Gmbh Verfahren zur Herstellung von Absorptionsmaterial auf Polymerbasis mit Zusatz von wasserlöslichen Substanzen und Verwendung dieses Absorptionsmaterials zur Aufnahme und/oder zur nachfolgenden Abgabe von Wasser oder wäßrigen Lösungen
DE4032096C2 (de) * 1990-10-10 1995-03-30 Boehringer Ingelheim Kg Verwendung emulgatorfreier Emulsionspolymere in pharmazeutischen Zubereitungen mit verzögerter Wirkstofffreigabe
US5266331A (en) * 1991-11-27 1993-11-30 Euroceltique, S.A. Controlled release oxycodone compositions
US20080075781A1 (en) * 1992-11-25 2008-03-27 Purdue Pharma Lp Controlled release oxycodone compositions
US20070275062A1 (en) * 1993-06-18 2007-11-29 Benjamin Oshlack Controlled release oxycodone compositions
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
DE4406424A1 (de) * 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
US6699963B2 (en) 2002-03-18 2004-03-02 The Procter & Gamble Company Grinding process for plastic material and compositions therefrom
US6770099B2 (en) 2002-11-19 2004-08-03 Zimmer Technology, Inc. Femoral prosthesis
CA2616204C (en) * 2005-09-09 2015-12-01 Labopharm Inc. Sustained drug release composition
US20070160960A1 (en) * 2005-10-21 2007-07-12 Laser Shot, Inc. System and method for calculating a projectile impact coordinates
US20100297226A1 (en) * 2006-06-01 2010-11-25 Dexcel Pharma Technologies Ltd. Multiple unit pharmaceutical formulation
US7985419B1 (en) 2006-12-22 2011-07-26 Watson Laboratories, Inc. Divisible tablet and associated methods
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB768291A (en) * 1953-12-16 1957-02-13 Schering Corp Pharmaceutical tablets
BE575343A (no) * 1955-09-09
US2987445A (en) * 1958-10-10 1961-06-06 Rohm & Haas Drug composition
US3087860A (en) * 1958-12-19 1963-04-30 Abbott Lab Method of prolonging release of drug from a precompressed solid carrier
BE632692A (no) * 1963-05-28
CH468192A (de) * 1964-06-19 1969-02-15 Ciba Geigy Verfahren zur Herstellung von Arzneimitteln in Perlenform
AT270071B (de) * 1966-08-12 1969-04-10 Roehm & Haas Gmbh Dragierlack für Arzneiformen
US3608063A (en) * 1969-08-15 1971-09-21 Gilbert S Banker Molecular drug entrapment process and compositions
US3629392A (en) * 1969-08-15 1971-12-21 Gilbert S Banker Entrapment compositions and processes
DE2031871C3 (de) * 1970-06-27 1974-06-27 Roehm Gmbh, 6100 Darmstadt Überzugsmasse für Arzneiformen
CH582002A5 (no) * 1972-06-09 1976-11-30 Purdue Research Foundation
US4013820A (en) * 1974-11-07 1977-03-22 Abbott Laboratories Universally useable tableting ingredients
JPS51118817A (en) * 1975-04-08 1976-10-19 Nippon Shinyaku Co Ltd A process for preparing absorbable steroid glycoside pharmaceutical
US4248855A (en) * 1976-08-27 1981-02-03 Hydrophilics International, Inc. Pharmaceutical base salts
US4391797A (en) * 1977-01-05 1983-07-05 The Children's Hospital Medical Center Systems for the controlled release of macromolecules
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
NZ189022A (en) * 1977-12-08 1981-11-19 Beecham Group Ltd Pharmaceutically acceptable particles of clavulanates dispersed in a polymeric binder
DD146547A5 (de) * 1978-07-15 1981-02-18 Boehringer Sohn Ingelheim Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
US4152415A (en) * 1978-08-18 1979-05-01 Iowa State University Research Foundation, Inc. Method of increasing the effectiveness of oral vaccination for swine dysentery
US4152413A (en) * 1978-08-18 1979-05-01 Chromalloy American Corporation Oral vaccine for swine dysentery and method of use
US4152414A (en) * 1978-08-18 1979-05-01 Iowa State University Research Foundation, Inc. Combination vaccine for swine dysentery and method of use
FI63335B (fi) * 1979-02-02 1983-02-28 Orion Yhtymae Oy Foerfarande foer framstaellning av tabletter med foerdroejd loslighet av effektaemne
US4258027A (en) * 1979-03-26 1981-03-24 Mead Johnson & Company Multi-fractionable tablet structure
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
US4353887A (en) * 1979-08-16 1982-10-12 Ciba-Geigy Corporation Divisible tablet having controlled and delayed release of the active substance
DE3170764D1 (en) * 1980-11-12 1985-07-04 Ciba Geigy Ag Fast disaggregating pharmaceutical tablet
DE3124090A1 (de) * 1981-06-19 1983-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale dipyridamolformen
US4357312A (en) * 1981-07-16 1982-11-02 The Children's Hospital Medical Center Method of making prolonged release body
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
GB2119648A (en) * 1982-05-06 1983-11-23 Joseph Hodgson Briggs Anorexogenic pharmaceutical composition
DE3314003A1 (de) * 1983-04-18 1984-10-18 Boehringer Ingelheim KG, 6507 Ingelheim Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung

Also Published As

Publication number Publication date
GR79858B (no) 1984-10-31
ES531684A0 (es) 1985-04-16
GB2138290A (en) 1984-10-24
GB8410010D0 (en) 1984-05-31
NO164957B (no) 1990-08-27
PH19612A (en) 1986-05-27
IE840945L (en) 1984-10-18
DK161183B (da) 1991-06-10
CA1232202A (en) 1988-02-02
NO164957C (no) 1990-12-05
EP0122574B2 (de) 1990-10-10
ZA842815B (en) 1985-12-24
FI80590C (fi) 1990-07-10
ATE23110T1 (de) 1986-11-15
AU2701184A (en) 1984-10-25
DK119084A (da) 1984-10-19
IE57141B1 (en) 1992-05-06
EP0122574B1 (de) 1986-10-29
DK161183C (da) 1991-11-25
EP0122574A1 (de) 1984-10-24
HU191558B (en) 1987-03-30
FI80590B (fi) 1990-03-30
HUT34350A (en) 1985-03-28
JPS59205313A (ja) 1984-11-20
SG68889G (en) 1990-01-26
PL144291B1 (en) 1988-05-31
US4547359A (en) 1985-10-15
FI841508A (fi) 1984-10-19
DK119084D0 (da) 1984-02-28
AU575045B2 (en) 1988-07-21
JPH0623096B2 (ja) 1994-03-30
PT78434A (de) 1984-05-01
HK1690A (en) 1990-01-19
PT78434B (de) 1986-08-22
KR910001924B1 (ko) 1991-03-30
GB2138290B (en) 1986-10-29
US4595587A (en) 1986-06-17
DD223063A5 (de) 1985-06-05
SU1356951A3 (ru) 1987-11-30
PL247289A1 (en) 1985-07-16
KR840008281A (ko) 1984-12-14
NZ207876A (en) 1986-10-08
DE3314003A1 (de) 1984-10-18
FI841508A0 (fi) 1984-04-16
CS247079B2 (en) 1986-11-13
IL71558A (en) 1987-10-30
ES8504453A1 (es) 1985-04-16
IL71558A0 (en) 1984-07-31
US4683131A (en) 1987-07-28
DE3461054D1 (en) 1986-12-04

Similar Documents

Publication Publication Date Title
NO841518L (no) Delbare tabletter med forsinket frigjoering av virkestoff, og fremgangsmaate for fremstilling derav
ES2061799T3 (es) Nuevo preparado medicamentoso y procedimiento para su preparacion.
DK108888D0 (da) Farmaceutisk tablet, farmaceutisk granulat og fremgangsmaader til fremstilling af henholdsvis denne tablet og dette granulat
HUT47131A (en) Process for producing steroid-5alpha-reductase inhibitors and pharmaceutical compositions comprising them as active ingredient
HUT51269A (en) Process for producing benzimidazole derivatives and pharmaceutical compositions comprising same
NO884638D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetraliner, kromaner og beslektede forbindelser.
HUT48605A (en) Fungicides comprising hydroxyalkylazolyl derivatives as active ingredient and process for producing the active ingredient
AU2793989A (en) Method for preparing a solid sustained release form of a functionally active composition and the dosage form so obtained
HU890442D0 (en) Process for the production of new carbinole derivatives and medical preparations containing them, and agrochemical preparations containing such carbinole derivatives
IT1209896B (it) Antibiotico bmg162-af2 procedimento per la sua produzione e medicinale antitumorale contenente il suddetto antibiotico come ingrediente attivo
HUT47233A (en) Process for producing pharmaceutical comprising phenol derivatives as active ingredient and for producing the active ingredients
DE3479728D1 (en) Derivatives of thiophenesulfonamide, their preparation and pharmaceutical composition for the topical treatment of elevated intraocular pressure
DK162017C (da) Farmaceutisk tablet med kontrolleret frigivelse og fremgangsmaade til dens fremstilling
DE3064773D1 (en) Novel quinazoline derivatives, a pharmaceutical composition containing such derivatives as active ingredient and a process for producing the quinazoline derivatives
HUT48606A (en) Fungicides comprising hydroxyalkyltriazolyl derivatives as active ingredient and process for producing the active ingredients
DE3469438D1 (en) Novel, physiologically active substance, process for production thereof and pharmaceutical composition containing the same
HUT49855A (en) Insecticides and nematocides comprising 5-ethylamino-1-arylpyrazole derivatives as active ingredient and process for producing the active ingredients
HUT47548A (en) Fungicides comprising dicyano-pyrazine derivatives as active ingredient and process for producing the active ingredients
HUT50807A (en) Process for producing pharmaceutical compositions comprising labdane derivatives as active ingredient and for producing the active ingredient
IT8821881A0 (it) Farmaci per la profilassi e la terapia del deterioramento celebrale senile (d.s.c.)procedimento per la loro preparazione e composizioni far maceutiche che li contengono

Legal Events

Date Code Title Description
MK1K Patent expired